Last reviewed · How we verify

NCT06906965: IMERACAROBGLUC

Effect of the Imera Cultivar Carob in Postprandial Glycemia

Completed NA Last updated 6 April 2025
What this trial tests

NA trial testing Carob beverage in Postprandial Glucose Regulation in 15 participants. Completed in 30 September 2024.

Timeline
31 January 2024
Primary endpoint
31 May 2024
30 September 2024

Quick facts

Lead sponsorHarokopio University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment15
Start date31 January 2024
Primary completion31 May 2024
Estimated completion30 September 2024
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Harokopio University

Who can join

18 and older, male only, with Postprandial Glucose Regulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An acute randomized crossover study on the effect of a carob beverage on postprandial glycemic response

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Carob beverage

Trials testing the same drug.

Other Harokopio University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06906965.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing